Most pharmacies that closed between 2009 and 2015 in the United States were independent drugstores in low-income urban areas with underserved populations.
Addressing this autoimmune disorder characterized by thrombosis or pregnancy morbidity coupled with persistent antiphospholipid antibodies involves identifying and mitigating thrombosis risk factors.
Newer drugs are more targeted than standard agents, but their incorporation into treatment regimens is challenging because of the risk of cardiovascular and infectious adverse events.
Janus kinase inhibitors effectively treat rheumatoid arthritis, but their use in smokers aged older than 65 years and certain other populations potentiates the risk of adverse events.
In both rural and urban areas, the number of patients who go to pharmacies for vaccinations has continued to increase each year.
Many patients with this life-threatening bacterial infection present with nonspecific symptoms that prompt a broad medical workup to rule out other potential sources of infection.